Total Funding
45
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
38679
Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
Acquired by 
Sunbird Bio
- Matthew Navarro: Chief Financial Officer
- Gabe Kwong: Co-FounderPast Role: Glympse Bio, Co-Founder and Chief Scientific Officer
About the Company
Glympse Bio develops a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis.
Glympse Bio’s platform technology
was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
Women Founded
